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ABSTRACT: Substantial progress has been described in the development of
asymmetric variants of the phosphine-catalyzed intermolecular [3+2] annulation of
allenes with alkenes; however, there have not been corresponding advances for the
intramolecular process, which can generate a higher level of complexity (an additional
ring and stereocenter(s)). In this study, we describe the application of chiral
phosphepine catalysts to address this challenge, thereby providing access to useful
scaﬀolds that are found in bioactive compounds, including diquinane and quinolin-2-one
derivatives, with very good stereoselectivity. The products of the [3+2] annulation can
be readily transformed into structures that are even more stereochemically rich.
Mechanistic studies are consistent with β addition of the phosphepine to the allene being the turnover-limiting step of the
catalytic cycle, followed by a concerted [3+2] cycloaddition to the pendant oleﬁn.
■ INTRODUCTION
During the past decade, the use of chiral tertiary phosphines as
enantioselective nucleophilic catalysts has expanded rapidly.1
The phosphine-catalyzed [3+2] annulation of electron-poor
allenes (or alkynes) with oleﬁns, originally described by Lu,2
represents a powerful approach to the synthesis of functionalized
cyclopentenes (eq 1).3 Zhang reported the ﬁrst example of an
asymmetric variant of this method,4 and we5 and others6 have
since enlarged the scope of such processes.7
Krische8 and Kwon9 have established that the intramolecular
version of the Lu [3+2] annulation can circumvent the formation
of isomeric products and generate an array of useful, stereo-
chemically rich fused ring systems, including diquinane and
coumarin derivatives.10,11 To date, despite the considerable
progress that has been described for asymmetric catalysis of the
intermolecular Lu annulation,4−6 there has been no correspond-
ing success with intramolecular reactions, wherein the
conformation of the stereochemistry-determining transition
state is relatively constrained. In this Article, we establish that
such catalytic enantioselective intramolecular [3+2] annulations
can indeed be achieved, thereby aﬀording functionalized, fused
bicyclic ring systems that bear multiple contiguous stereocenters
(eqs 2 and 3).
■ RESULTS AND DISCUSSION
In our initial studies, we chose to focus on the enantioselective
synthesis of diquinanes, which Krische has established can be
generated eﬀectively in racemic form with P(n-Bu)3 as the
catalyst.8 We have reported earlier that phosphepines can serve
as useful chiral nucleophilic catalysts,12,13 and we have now
determined that previously described phosphines 1−3 do indeed
furnish promising results in the target annulation (eq 4).
Furthermore, new chiral phosphepine 4,14 which bears a 3,5-
dimethoxyphenyl group on phosphorus, catalyzes the formation
of the desired diquinane in excellent ee and high yield (eq 4;
single diastereomer).15,16
Phosphepine 4 serves as an eﬀective catalyst for the highly
enantioselective synthesis of an array of diastereomerically pure
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diquinanes (and related structures) from acyclic precursors,
generating two rings and three contiguous tertiary stereocenters
in the process (Table 1).17 The electron-withdrawing group of
the allene can be any of an array of esters, and the electron-
withdrawing substituent of the alkene can be an ester, thioester,
or amide (e.g., entries 1−6).18 Signiﬁcantly, good enantiose-
lectivity and yield are observed with a variety of tethers between
the allene and the alkene (entries 7−10), thereby furnishing a
fused pyrrolidine as well as a benzannulated diquinane. These
annulations are stereoconvergent processes wherein both
enantiomers of the racemic allene are being converted by the
chiral catalyst into the same stereoisomer of the product with
good selectivity.
Next, we turned our attention to the challenge of achieving
enantioselective intramolecular [3+2] annulations of substrates
that include a trisubstituted oleﬁn.19 We have determined that
chiral phosphepines can indeed catalyze the desired annulations
with good enantioselectivities and yields, as well as complete
diastereoselectivity (Table 2). Any of a variety of linkers between
the allene and the alkene are tolerated, as are diﬀerent classes of
trisubstituted oleﬁns, thereby aﬀording an array of products that
include a quaternary stereocenter.20
We sought to demonstrate that the scope of this new method
for catalytic enantioselective intramolecular [3+2] cycloaddi-
tions extends beyond the synthesis of diquinane-like structures.
Building on Kwon’s report of P(n-Bu)3-catalyzed, diastereose-
lective [3+2] annulations to furnish fused dihydrocoumarins,9 we
have developed an enantioselective variant of this reaction that
proceeds in very good ee and yield (eq 5; a single diastereomer).
Encouraged by this result, we decided to pursue the
application of our method to the catalytic asymmetric synthesis
of fused quinolin-2-ones, a motif found in an array of bioactive
compounds21 and which to our knowledge has not previously
been generated via such a [3+2] annulation.We have determined
Table 1. Phosphine-Catalyzed Enantioselective
Intramolecular [3+2] Annulationsa
aAll data are the average of two experiments. bYield of puriﬁed
product; only one diastereomer was observed (analysis of the
unpuriﬁed mixture by 1H NMR spectroscopy). cReaction temperature:
40 °C. dCatalyst (S)-2 (20%) was employed instead of (S)-4.
Table 2. Catalytic Enantioselective Intramolecular [3+2]
Annulations: Trisubstituted Oleﬁns as a Reaction Partnera
aAll data are the average of two experiments. bYield of puriﬁed
product; only one diastereomer was observed (analysis of the
unpuriﬁed mixture by 1H NMR spectroscopy). cCatalyst loading: 20%.
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that phosphepine 4 does indeed catalyze the desired trans-
formation with moderate-to-good enantioselectivity and in high
yield, thereby aﬀording two rings and two adjacent stereocenters
(Table 3). The substrates may include either a di- or a
trisubstituted oleﬁn.
Diastereoselective functionalization of the various annulation
products can provide additional stereocenters. For example,
hydrogenation and epoxidation proceed with high stereo-
selectivity and yield (eqs 6 and 7).
An outline of a possible mechanism for the phosphine-
catalyzed enantioselective intramolecular [3+2] annulation of
allenes with alkenes is depicted in Figure 1.7 Nucleophilic
addition of the phosphine to the β position of the allene
generates zwitterion A, which undergoes a cycloaddition with the
alkene, furnishing a new zwitterion (B), which tautomerizes toC.
Fragmentation then aﬀords the bicyclic product and regenerates
the phosphine catalyst.
When an asymmetric intramolecular [3+2] annulation is
stopped at partial conversion, modest enantiomeric enrichment
of the unreacted allene is observed (eq 8; s∼ 2.7), indicating that
the chiral catalyst can discriminate between the enantiomers of
the racemic substrate.22,23 Taking into account our observation
that the predominant resting state of the catalyst during the
reaction is the free phosphine (31P NMR spectroscopy), we
hypothesize that the ﬁrst step of the catalytic cycle is likely the
turnover-limiting step (Figure 1).
Finally, to gain insight into whether ring formation (A→ B in
Figure 1) occurs through a concerted or through a stepwise
pathway, we have examined the conﬁguration of the product as a
function of the conﬁguration of the oleﬁn of the starting material.
The stereochemical outcomes for all of the reactions described
above are consistent with a concerted mechanism; however,
there are no direct comparisons between corresponding E and Z
oleﬁns. We therefore investigated the [3+2] annulation of the Z
isomer of the substrate depicted in entry 1 of Table 1, and we
have determined that it leads to the epimeric diquinane as a single
isomer (eq 9), consistent with formation of the ﬁve-membered
ring via a concerted pathway.24
■ CONCLUSIONS
We have developed the ﬁrst phosphine-catalyzed enantioselec-
tive intramolecular [3+2] cycloadditions of allenes with oleﬁns, a
Table 3. Catalytic Enantioselective Intramolecular [3+2]
Annulations To Generate Quinolin-2-one Derivativesa
aAll data are the average of two experiments. bYield of puriﬁed
product; only one diastereomer was observed (analysis of the
unpuriﬁed mixture by 1H NMR spectroscopy). cCatalyst loading:
20% (S)-4. dCatalyst loading: 10% (S)-4
Figure 1. An outline of a possible mechanism for phosphine-catalyzed
enantioselective intramolecular [3+2] annulations of allenes with
alkenes.
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process that generates two new rings and multiple stereogenic
centers. Thus, an array of diasteromerically pure fused ring
systems that are found in bioactive compounds, including
diquinane and quinolin-2-one derivatives, are produced in
generally good ee and yield with the aid of chiral phosphepine
catalysts; furthermore, the bicyclic reaction products are well-
suited for further diastereoselective functionalizations. Mecha-
nistic studies establish that the chiral catalyst has a modest
preference for reaction with one of the enantiomers of the
racemic substrate and that the rate-determining step for the
overall process is likely the initial addition of the phosphepine to
the allene; the resulting adduct then undergoes a concerted
intramolecular [3+2] cycloaddition with the pendant oleﬁn.
Further studies of enantioselective nucleophile-catalyzed pro-
cesses are underway.
■ EXPERIMENTAL SECTION
General Procedure.The phosphine catalyst (0.10 equiv) was added
to an oven-dried 20 mL vial equipped with a stir bar. This vial was
capped with a septum-lined cap, the joint was covered with electrical
tape, and then the vial was evacuated and backﬁlled with nitrogen (three
cycles). The substrate (1.00 equiv) was added to a separate vial, which
was then capped with a septum-lined cap, the joint was covered with
electrical tape, and then the vial was evacuated and backﬁlled with
nitrogen (three cycles). Next, toluene (anhydrous) was added to the vial
that contained the substrate. This solution was added via syringe to the
vial that contained the catalyst (under a positive pressure of nitrogen).
Next, the reaction vial was detached from the nitrogen manifold, and
grease was applied to the puncture hole in the septum in order to impede
moisture/air from entering the vial. The reaction mixture was stirred at
room temperature for 24 h, and then an aqueous solution of hydrogen
peroxide (10%; 1.0 mL) was added. The resulting mixture was stirred for
10 min, and then an aqueous solution of Na2S2O3 (saturated; 2.0 mL)
was added. The mixture was stirred for 10 min, and then the aqueous
layer was extracted with EtOAc (5 mL × 3), and the combined organic
layers were dried over MgSO4 and then concentrated under reduced
pressure. The resulting residue was puriﬁed by column chromatography.
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